Literature DB >> 22902565

Proconvertase proteolytic processing of an enzymatically active myeloperoxidase precursor.

Sally McCormick1, Angela Nelson, William M Nauseef.   

Abstract

Optimal and efficient killing of ingested microbes by human neutrophils is mediated in large part by the action of hypochlorous acid produced by the myeloperoxidase-H(2)O(2)-chloride system in phagosomes. Myeloperoxidase gene transcription is limited to early myeloid precursors in the bone marrow, when myeloperoxidase is synthesized and stored in azurophilic granules for subsequent release from stimulated neutrophils. Promyeloperoxidase, the 90 kDa myeloperoxidase precursor synthesized in the endoplasmic reticulum (ER), contains a 125-amino acid pro-region whose function and fate during myeloperoxidase biosynthesis are unknown. Promyeloperoxidase has two fates during myeloperoxidase biosynthesis; the majority undergoes proteolytic processing to generate mature myeloperoxidase, while the remainder is constitutively secreted from the cells in bone marrow. We used a promyelocytic cell line that produces endogenous myeloperoxidase as well as human embryonic kidney cells stably expressing normal and mutant forms of myeloperoxidase to examine proteolytic processing of promyeloperoxidase. We demonstrated that CMK-RVKR, an inhibitor of subtilisin-like proteinases, blocked cleavage of the pro-peptide of promyeloperoxidase in a post-ER compartment. Mutants with alanine substitution of basic residues in the predicted proteinase cleavage site failed to undergo maturation to normal myeloperoxidase subunits and were arrested at the promyeloperoxidase stage. Whereas specific mutants varied as to their stability, secreted promyeloperoxidase from the mutants retained the capacity to generate hypochlorous acid. Taken together, these studies demonstrate proconvertase-dependent cleavage of promyeloperoxidase as an essential step in normal proteolytic processing and granule targeting of myeloperoxidase. Furthermore, although mutations in the proteinase cleavage site reduced intracellular stability of the mutants, the integrity of the heme group was not compromised, as chlorinating activity was retained in the secreted promyeloperoxidase. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22902565      PMCID: PMC3459156          DOI: 10.1016/j.abb.2012.07.013

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  48 in total

1.  Evidence for the involvement of an acidic compartment in the processing of myeloperoxidase in human promyelocytic leukemia HL-60 cells.

Authors:  D T Akin; J M Kinkade
Journal:  Arch Biochem Biophys       Date:  1987-06       Impact factor: 4.013

2.  Molecular forms of myeloperoxidase in human plasma.

Authors:  R L Olsen; T K Steigen; T Holm; C Little
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

3.  Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase.

Authors:  W M Nauseef; M Cogley; S McCormick
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

4.  Myeloperoxidase: its structure and expression during myeloid differentiation.

Authors:  H P Koeffler; J Ranyard; M Pertcheck
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

5.  The processing and intracellular transport of myeloperoxidase. Modulation by lysosomotropic agents and monensin.

Authors:  K Strömberg; A M Persson; I Olsson
Journal:  Eur J Cell Biol       Date:  1986-01       Impact factor: 4.492

6.  Myeloperoxidase biosynthesis by a human promyelocytic leukemia cell line: insight into myeloperoxidase deficiency.

Authors:  W M Nauseef
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

7.  Processing of a newly identified intermediate of human myeloperoxidase in isolated granules occurs at neutral pH.

Authors:  D T Akin; J M Kinkade
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

8.  Biosynthesis, transport and processing of myeloperoxidase in the human leukaemic promyelocytic cell line HL-60 and normal marrow cells.

Authors:  I Olsson; A M Persson; K Strömberg
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

9.  Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency.

Authors:  W M Nauseef; R K Root; H L Malech
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  The development of neutrophilic polymorphonuclear leukocytes in human bone marrow.

Authors:  D F Bainton; J L Ullyot; M G Farquhar
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Biosynthesis of human myeloperoxidase.

Authors:  William M Nauseef
Journal:  Arch Biochem Biophys       Date:  2018-02-03       Impact factor: 4.013

2.  Cellular Uptake and Delivery of Myeloperoxidase to Lysosomes Promote Lipofuscin Degradation and Lysosomal Stress in Retinal Cells.

Authors:  Gouri Yogalingam; Amanda R Lee; Donald S Mackenzie; Travis J Maures; Agnes Rafalko; Heather Prill; Geoffrey Y Berguig; Chuck Hague; Terri Christianson; Sean M Bell; Jonathan H LeBowitz
Journal:  J Biol Chem       Date:  2017-01-23       Impact factor: 5.157

3.  Proprotein Convertase Processing Enhances Peroxidasin Activity to Reinforce Collagen IV.

Authors:  Selene Colon; Gautam Bhave
Journal:  J Biol Chem       Date:  2016-10-03       Impact factor: 5.157

4.  T47D Cells Expressing Myeloperoxidase Are Able to Process, Traffic and Store the Mature Protein in Lysosomes: Studies in T47D Cells Reveal a Role for Cys319 in MPO Biosynthesis that Precedes Its Known Role in Inter-Molecular Disulfide Bond Formation.

Authors:  Richard P Laura; David Dong; Wanda F Reynolds; Richard A Maki
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

5.  Structure of human promyeloperoxidase (proMPO) and the role of the propeptide in processing and maturation.

Authors:  Irina Grishkovskaya; Martina Paumann-Page; Rupert Tscheliessnig; Johanna Stampler; Stefan Hofbauer; Monika Soudi; Benjamin Sevcnikar; Chris Oostenbrink; Paul G Furtmüller; Kristina Djinović-Carugo; William M Nauseef; Christian Obinger
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

6.  Recombinant Myeloperoxidase as a New Class of Antimicrobial Agents.

Authors:  Zehong Cao; Guangjie Cheng
Journal:  Microbiol Spectr       Date:  2022-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.